📰 Launch Dynamix News
Page 2 - Launch Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Launch Dynamix. Real-time updates on events, politics, business and more.
March 27, 2023
/PRNewswire/ -- In the 32nd wave of ongoing tracking of the U.S. Renal Anemia market, Spherix surveyed 207 US nephrologists about overall patient management...
March 17, 2023
/PRNewswire/ -- When the FDA approved Rebyota, a new class of Clostridioides Difficile (C.diff) treatment, Ferring Pharmaceuticals ushered in the first...
February 28, 2023
/PRNewswire/ -- On February 16, The Lancet Neurology published the Phase 3 results of Pfizers zavegepant for the acute treatment of migraine. The CGRP...
February 24, 2023
/PRNewswire/ -- Argenxs launch of Vyvgart (efgartigimod) has been a success, with global first-year revenue of ~$400 million USD. As the second biologic...
February 17, 2023
/PRNewswire/ -- According to Biogens earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third...
February 9, 2023
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists perceptions and...
December 9, 2022
/PRNewswire/ -- On September 9, 2022, BMS announced the FDA approval of Sotyktu for moderate-to-severe plaque psoriasis (PsO), making it the first selective...
November 17, 2022
/PRNewswire/ -- On June 13, 2022, Eli Lilly announced the FDA approval of Olumiant for severe alopecia areata (AA), making it the first systemic therapy...
November 17, 2022
/PRNewswire/ -- On June 13, 2022, Eli Lilly announced the FDA approval of Olumiant for severe alopecia areata (AA), making it the first systemic therapy...
October 19, 2022
/PRNewswire/ -- Spherix Global Insights, a leading market intelligence firm specializing in nephrology, is excited to announce the titles of four abstracts...